Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.
An at-home brain-computer interface improves upper limb motor function in patients with chronic stroke, suggesting a new avenue for long-term neurorehabilitation.
Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.
An individual patient-level meta-analysis shows that tenecteplase, a next-generation thrombolytic, is at least as effective as alteplase for acute stroke — and may be superior.
